South China Botanical Garden, Chinese Academy of Sciences, China
Assist Prof. Dr. Xiancai Li is a dedicated pharmacological researcher recognized for his strong contributions to plant-based therapeutic discovery, particularly in the antimicrobial and uric-acid-lowering potential of natural products. With extensive experience in molecular biology and phytochemical research, he has developed deep expertise in transcriptomic and metabolomic analysis, enabling him to elucidate complex biochemical pathways and identify novel bioactive compounds. He earned his Bachelor of Science in plant protection, followed by a Ph.D. in science, where he focused on natural product pharmacology and plant-derived mechanisms of disease mitigation. His postdoctoral research at the Institute of Genetics and Developmental Biology further strengthened his proficiency in functional genomics and biological validation techniques, leading to several impactful publications in reputable scientific journals. Currently serving as a Research Associate at the South China Botanical Garden, Chinese Academy of Sciences, he continues to advance innovative pharmacological studies with an emphasis on plant resources for drug discovery. His research interests span antimicrobial resistance, metabolic regulation, phytotherapy, and natural product innovation. Throughout his career, he has been recognized with academic honors and research achievements that highlight his commitment to scientific excellence. Dr. Li remains dedicated to advancing evidence-based natural medicine and contributing to global health solutions.
Featured Publications
Li, X., Yu, W., Yao, L., Liu, F., Li, Y., Xiong, B., Xie, J., & Qiu, S.-X. (2026). “Amelioration effects of Cajanus cajan extracts and the active ingredient pinostrobin on hyperuricemia and related kidney injury.” Food & Function.
https://doi.org/10.1039/D5FO01806D
Li, X., Chen, S., Wu, Y., Liu, F., Jumai, A., Zhu, B., Xiong, B., & Qiu, S.-X. (2026). “γ-mangostin from Garcinia mangostana (L.) exerts antifungal activity against Cryptococcus neoformans by inhibiting ribosome biogenesis.” Journal of Ethnopharmacology, March 2026. https://doi.org/10.1016/j.jep.2025.120986